In previous experiments, hybrids (YC) from two mouse malignant cells (L1210 and Cl.1D) failed to develop tumors in adult compatible hosts (1) . However, it appeared doubtful that malignancy of both parental cells was suppressed by complementation (2) , because YC hybrids in culture had characteristics of malignant cells (1) , and expressed the tumor-associated transplantation antigens of L1210 parental cells (3) . Further, hybrids between the same Cl.1D cell line and mouse teratocarcinoma cells were malignant (4) .
Experiments reported here demonstrate that the inability of YC hybrids to grow in vivo is due to histocompatibility factors. As Cl.lD and L1210 cells, either separately or mixed together, produced tumors in F, mice (1) , an analysis of hybrid-tumor-associated antigens was performed. Three possible hypotheses were considered to explain the efficiency of immune reaction. First, hybrid cells might express parental-tumor-associated antigens in a greater amount than parental cells. Second, silent genes in parental cells might express themselves upon hybridization (5) , resulting in new antigens on the surface of hybrids. Third, hybrid molecules on hybrid cell surface, having new antigenic determinants, might result from combination of molecule subunits coded by homologous parental genes in hybrids. The existence of hybrid molecules in somatic cell hybrids is well documented (6) . (Table 3) . Therefore, tumors might have developed as a consequence of some specific chromosome loss (2) .
To test this hypothesis, we grafted fragments from the tumors examined for their karyotypes (or, in some instances, 2.5 X 108 cells explanted from the same tumors) to unirradiated adult F1 mice. None of the 88 mice tested developed tumors within 9 months (Table 2 ). It was concluded that YC hybrids failed to grow in adult mice because of immune rejection, and grew in x-irradiated newborn because the hosts were immunologically incompetent.
Histology of Hybrid Tumors. Three different histologic features were observed. (1) Fibrosarcoma (Fig. 1) (Fig. 2) , closely resembling those developed when parental L1210 leukemia cells were (1) .
Syngeneic Antisera Against Y2C Hybrids. Sera of F1 mice immunized with Y2C hybrids were pooled, and two pools were tested for cytotoxic antibodies, using parental and hybrid cells as target cells. Fig. 4 shows titration curves of the pool of sera used in the absorption experiments described below. Titers for Y2C, Cl.lD, and L1210 target cells were 160, 80, and 15, respectively. Similar relative titers were found with the other pool of sera for the three target cells (110, 40, and 5, respectively). Thus, Y2C hybrids were more sensitive to antibodies than either of the parental cells.
Absorption Experiments. Cytotoxic antibodies against all three target cell lines were completely absorbed by incubating sera with Y2C cells (Fig. 5) .
Aliquots of antisera were absorbed Y2C target cells were completely absorbed, indicating that there was no new surface antigen on Y2C hybrid cells, i.e., antigen absent on parental cells (Fig. 6 ).
50% of antibodies cytotoxic for Cl.1D target cells were absorbed by half as many Y2C cells (Fig. 7) , indicating that Y2C cells had two times more "Cl.1D" antigenic sites than Cl.1D cells. 50% of antibodies cytotoxic for L1210 target cells were absorbed by the same number of Y2C as L1210 cells (Fig. 8) , showing that Y2C and L1210 cells had approximately the same number of "L1210" antigenic sites.
Diameters of 100 cells of each line were measured with an ocular micrometer, and mean surface areas were calculated. Since the ratios of Y2C:Cl.lD and Y2C:L1210 cell surfaces were 5:4 and 2:1, respectively, "Cl.1D" and "L1210" antigenic site densities on Y2C cells were estimated to be about 1.6 Rejection by adult F1 mice of all secondary grafts of YC tumors developed in x-irradiated newborn demonstrates that, even if some telocentric chromosomes were lacking in hybrid tumors, specific chromosome losses are not responsible for YC growth in newborn mice, and that suppression of malignancy (2) did not occur in YC hybrid cell populations. In this respect, YC hybrids are comparable to hybrids derived from highly malignant A9HT and mouse tumor cells (9) . Hybrids between two malignant cells always appear malignant (4, 9-15), i.e., the characters determining malignancy do not show complementation (15) .
Graft experiments reported here demonstrate that YC hybrids fail to grow because they are rejected by adult hosts. Analysis of an antiserum prepared by injecting Y2C hybrids into syngeneic F1 (Fig. 5) . Since absorption by Y2C cells removes both anti-"Cl.1D" and anti-"L1210" antibodies present in the antiserum, it is possible that anti-"Cl.1D" and anti-"L1210" antibodies attached to their respective antigenic sites on hybrid cell surface cooperate in binding complement, as intermixing of antigenic sites of both parental cell origins (16, 17) small area in two of eight tumors, suggests that information for lymphoid morphology is carried cryptically for many generations in hybrid cells (23) .
